Proteros
Martinsried · Founded 1998
About Proteros
Proteros is a biotech company focused on enabling lead discovery for challenging targets. Proteros has established a profitable discovery service business with a best-in-class enabling technology platform for structure accelerated lead discovery. Their track record is proven by an outstanding project success rate. Proteros’ proprietary pipeline includes highly disease relevant target classes such as kinases, epigenetic targets and GPCRs. Their success is built on unique know how and expertise in understanding the role of protein structures involved in protein and small molecule interactions that are responsible for the pathogenesis of many diseases.
Company Facts
- Founded: 1998
- Legal name: Proteros biostructures GmbH
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $7.0M
- Funding stage: Private Equity
- Last round: Private Equity (Jan 2023)
- Website: proteros.com
- Phone: 49 89 7007610
Social Profiles
Canonical: https://fsome.com/organization/proteros-8370315 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.